News

Vivani Medical to Highlight Innovative Drug Delivery Solutions

Vivani Medical to Highlight Innovative Drug Delivery Solutions

Vivani Medical to Showcase at the Emerging Growth Conference

Vivani Medical, Inc. (NASDAQ: VANI), known for its pioneering work in biopharmaceutical innovation, has announced it will take part in the upcoming Emerging Growth Conference. This event presents a great opportunity for investors and stakeholders to learn more about Vivani's groundbreaking methods of drug delivery through cutting-edge implant technology.

Engaging Presentation for All Investors

Vivani invites individual and institutional investors, as well as financial advisors and analysts, to join an interactive online presentation. Scheduled for 1:10 p.m. Eastern Time, this live event will feature insights from the Company’s President and CEO, Adam Mendelsohn, Ph.D. He will discuss Vivani's vision and mission, followed by a Q&A session to address any questions from the audience directly.

Revolutionary Technology and Its Influence

Vivani Medical is widely recognized for its cutting-edge technology, which includes miniaturized, ultra-long-acting drug implants. These advanced devices are designed to consistently deliver medication over extended periods, promoting higher adherence to treatment plans, especially for chronic conditions. This novel drug delivery system aims to greatly enhance patient experiences by reducing the frequency of required dosing, thus improving overall treatment effectiveness.

Overview of the Product Pipeline

Vivani's flagship product, NPM-115, features a small implant designed for six months of administering GLP-1 (exenatide) to help manage chronic weight for individuals dealing with obesity. This product stands out by providing a reliable medication delivery solution, effectively addressing the common challenges associated with non-adherence.

Alongside NPM-115, Vivani is developing the NPM-139 implant, which utilizes semaglutide tailored to similar patient groups. This innovative implant has the potential to require administration only once a year, making it particularly attractive for patients seeking convenient treatment options. Additionally, the NPM-119 program targets Type 2 Diabetes management through a six-month subdermal exenatide implant, presenting a well-rounded approach to treating chronic diseases.

The Significance of Adherence in Treatment

Medication non-adherence is a worrying issue in healthcare, affecting about 50% of patients, particularly those with chronic diseases. This problem results in over $500 billion in avoidable healthcare costs in the U.S. each year, alongside a notable number of preventable deaths. Vivani understands this critical issue and designs its products to ensure that patients can fully benefit from their medications. By alleviating the daily burden of oral or injectable medications, Vivani aims to create a treatment experience that not only supports adherence but also contributes to achieving meaningful health outcomes.

Tackling a Growing Market

With the competitive landscape for GLP-1 therapies expanding—over 50 new molecular entities are in clinical development—Vivani Medical sets itself apart with its portfolio of long-acting implants. This distinctive capability allows Vivani to provide significant therapeutic options for patients, prescribers, and payers, opening a promising path for growth and advancement in the biopharmaceutical industry.

A Look at Cortigent, Inc.

Vivani's commitment to innovation extends beyond pharmaceuticals, encompassing its wholly-owned subsidiary, Cortigent, Inc. Cortigent specializes in developing precise neurostimulation systems designed to restore essential body functions for those with mobility impairments. Their flagship investigational devices include Orion®, aimed at offering artificial vision for profoundly blind individuals, and an innovative system to support recovery for those who are partially paralyzed due to stroke. Additionally, Cortigent has launched the Argus II® visual prosthetic device, which has already demonstrated the ability to restore meaningful vision.

Strategic Aspirations for Advancement

Vivani Medical is focused on exploring various strategic options to advance Cortigent's groundbreaking technology. The combination of biopharmaceutical progress with innovative neural assistance technology showcases Vivani's comprehensive approach to addressing diverse health challenges. Through these initiatives, the company aims to establish itself as a leader in both drug delivery and neurological recovery solutions.

Frequently Asked Questions

What is Vivani Medical known for?

Vivani Medical is known for its innovative biopharmaceutical implants that provide long-lasting drug delivery, enhancing adherence to treatment plans.

When will Vivani present at the Emerging Growth Conference?

Vivani is set to present at the conference on September 25, 2024, at 1:10 p.m. Eastern Time.

How do Vivani's implants enhance medication adherence?

The implants are designed to deliver medication over an extended period, minimizing the need for daily or weekly dosing and thereby improving adherence.

What are the key products in Vivani's product pipeline?

Key products include NPM-115 and NPM-139 for chronic weight management, along with NPM-119 for managing Type 2 Diabetes.

What does Cortigent, Inc. focus on?

Cortigent is a subsidiary of Vivani that develops neurostimulation systems aimed at restoring bodily functions, including vision rehabilitation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 100

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
Chicago Kertész Show Puts Photography's Quiet Giant First

Updated Category News Views 112

A fork, a plate, and a sharp eye can outlast plenty of louder art. Leica Gallery Chicago is putting that proposition on the wall with André Kertész: The Master, opening December 4, 2026 and running through January 17, 2027. More than thirty signature works is not a sprawling museum survey, and frankly that may be the point. Kertész did not need grand scale to make his...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 139

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 94

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
AMP Pushes Debt Wall to 2029 With €1.3B Green Notes

Updated Category News Views 108

A Refinancing With Some Actual Breathing Room Metal cans may be boring, but a debt wall arriving in 2028 is not—and Ardagh Metal Packaging has moved that problem down the road. AMP priced €1.3 billion of senior secured floating-rate green notes on November 20, 2026. The proceeds are earmarked to redeem $600 million of senior secured green notes due in 2028 and €450...

Continue Reading
Teachstone’s Bronze Award Puts Classroom Quality in Focus

Updated Category News Views 36

Small Classroom Moments Finally Get Their Due A child’s hesitant question can disappear in the noise of a busy classroom, which is precisely why Teachstone’s latest recognition deserves more than the usual polite golf clap. The Charlottesville-based Certified B Corporation received a Bronze Anthem Award for its “From Measurement to Momentum” initiative, in the...

Continue Reading
Shenzhen’s 50-Year Message Carries Real Trade Weight

Updated Category News Views 68

A city once framed as a frontier fishing village is being presented as China’s sharpest recent economic before-and-after picture. At the welcome dinner for the 33rd APEC Economic Leaders’ Meeting in Shenzhen, President Xi Jinping gave guests a compact geographic guide to China’s past: Xi’an for thousands of years, Beijing for 500 years, Shanghai for 100 years, and...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 127

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 65

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading

Top 5 Most Recently Viewed Articles

Ready Capital Corporation's 2024 Results Overview & Future Insights

Updated Category News Views 176

Ready Capital Corporation's Upcoming Financial Results Ready Capital Corporation (NASDAQ: RC) is poised to share its financial results for the fourth quarter and the full year of 2024. This significant announcement is expected to take place before the opening bell of the New York Stock Exchange on the designated release date. Investors and interested parties are eagerly...

Continue Reading
Nano-X Faces Securities Suit, Investors Alerted

Updated Category News Views 32

Legal Tsunami Hits Nano-X Imaging If there’s one thing that makes investors' hairs stand on end, it’s the words 'class action lawsuit.' And now, it's swirling around Nano-X Imaging Ltd. (NASDAQ: NNOX) like a tempest. The DJS Law Group has taken the lead, lighting the legal torches on claims that Nano-X fed investors a cocktail of misleading statements regarding its...

Continue Reading
Novo Nordisk A/S Shareholders: Take Action on Recent Allegations

Updated Category News Views 218

Understanding the Novo Nordisk A/S Class Action Opportunity Recent developments have led to significant scrutiny of Novo Nordisk A/S, a major player in the pharmaceutical industry. For shareholders, this highlights a crucial opportunity to engage in a class action lawsuit regarding alleged misleading statements about the company's CagriSema weight loss study results....

Continue Reading
Investors of Inspire Medical Systems Should Act Before Deadline

Updated Category News Views 288

Important Deadline for Inspire Medical Systems Investors Investors of Inspire Medical Systems, Inc. are reminded that a critical deadline is approaching for those who purchased securities. The firm Kirby McInerney LLP has encouraged investors to take action as they seek the lead plaintiff role in a federal securities class action. About the Legal Proceedings This lawsuit...

Continue Reading
Nicholas Wealth's Impressive $GIAX Distribution Yield Announcement

Updated Category News Views 88

Recent Announcement from Nicholas Wealth Management Nicholas Wealth, renowned for its commitment to delivering actively managed income ETFs, has made an exciting announcement regarding its latest distribution. The Nicholas Global Equity and Income ETF (GIAX) will offer investors a substantial monthly distribution yield of an impressive 24.00%. This announcement is...

Continue Reading